Analysis of tuberculous meningitis cases by an immunoblotting assay based on a mycobacterial antigen complex

Area of Science:

• Immunology
• Neurology
• Infectious Diseases

Background:

• Tuberculous meningitis (TBM) poses a significant diagnostic challenge, particularly in early stages.
• Reliable biomarkers are needed for timely and accurate diagnosis of TBM.

Purpose of the Study:

• To evaluate the diagnostic utility of anti-A60 immunoglobulin G (IgG) in cerebrospinal fluid (CSF) for tuberculous meningitis.
• To investigate the patterns of anti-A60 IgG synthesis and their correlation with disease presentation and recovery.

Main Methods:

• Immunoblotting assay using Mycobacterium bovis BCG antigen complex A60.
• Analysis of anti-A60 IgG levels in CSF and serum from TBM patients and controls.
• Assessment of intrathecal synthesis and oligoclonal IgG patterns in CSF.

Main Results:

• Anti-A60 IgG in CSF demonstrated potential for early TBM diagnosis.
• CSF anti-A60 IgG concentrations decreased post-recovery, indicating its utility in monitoring treatment.
• Distinct patterns of anti-A60 IgG were observed in primary meningitis versus meningeal complications of pulmonary tuberculosis, including intrathecal synthesis and mirror patterns.

Conclusions:

• The anti-A60 IgG immunoblotting test is a promising tool for early tuberculous meningitis diagnosis and monitoring.
• Analysis of anti-A60 IgG patterns in CSF can help differentiate TBM subtypes and assess disease activity.